Application of artificial intelligence in the assessment of thyroid eye disease (TED) - a scoping review.

Graves orbitopathy Graves’ ophthalmology artificial intelligence convolutional neural networks thyroid eye disease

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 23 09 2023
accepted: 21 11 2023
medline: 4 1 2024
pubmed: 4 1 2024
entrez: 4 1 2024
Statut: epublish

Résumé

There is emerging evidence which suggests the utility of artificial intelligence (AI) in the diagnostic assessment and pre-treatment evaluation of thyroid eye disease (TED). This scoping review aims to (1) identify the extent of the available evidence (2) provide an in-depth analysis of AI research methodology of the studies included in the review (3) Identify knowledge gaps pertaining to research in this area. This review was performed according to the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA). We quantify the diagnostic accuracy of AI models in the field of TED assessment and appraise the quality of these studies using the modified QUADAS-2 tool. A total of 13 studies were included in this review. The most common AI models used in these studies are convolutional neural networks (CNN). The majority of the studies compared algorithm performance against healthcare professionals. The overall risk of bias and applicability using the modified Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool led to most of the studies being classified as low risk, although higher deficiency was noted in the risk of bias in flow and timing. While the results of the review showed high diagnostic accuracy of the AI models in identifying features of TED relevant to disease assessment, deficiencies in study design causing study bias and compromising study applicability were noted. Moving forward, limitations and challenges inherent to machine learning should be addressed with improved standardized guidance around study design, reporting, and legislative framework.

Sections du résumé

Background UNASSIGNED
There is emerging evidence which suggests the utility of artificial intelligence (AI) in the diagnostic assessment and pre-treatment evaluation of thyroid eye disease (TED). This scoping review aims to (1) identify the extent of the available evidence (2) provide an in-depth analysis of AI research methodology of the studies included in the review (3) Identify knowledge gaps pertaining to research in this area.
Methods UNASSIGNED
This review was performed according to the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA). We quantify the diagnostic accuracy of AI models in the field of TED assessment and appraise the quality of these studies using the modified QUADAS-2 tool.
Results UNASSIGNED
A total of 13 studies were included in this review. The most common AI models used in these studies are convolutional neural networks (CNN). The majority of the studies compared algorithm performance against healthcare professionals. The overall risk of bias and applicability using the modified Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool led to most of the studies being classified as low risk, although higher deficiency was noted in the risk of bias in flow and timing.
Conclusions UNASSIGNED
While the results of the review showed high diagnostic accuracy of the AI models in identifying features of TED relevant to disease assessment, deficiencies in study design causing study bias and compromising study applicability were noted. Moving forward, limitations and challenges inherent to machine learning should be addressed with improved standardized guidance around study design, reporting, and legislative framework.

Identifiants

pubmed: 38174334
doi: 10.3389/fendo.2023.1300196
pmc: PMC10761414
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1300196

Informations de copyright

Copyright © 2023 Chng, Zheng, Kwee, Lee, Ting, Wong, Hu, Ooi and Kheok.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Chiaw-Ling Chng (CL)

Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.

Kaiping Zheng (K)

School of Computing, National University of Singapore, Singapore, Singapore.

Ann Kerwen Kwee (AK)

Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.

Ming-Han Hugo Lee (MH)

Oculoplastic Department, Sydney Eye Hospital, Sydney, SW, Australia.

Daniel Ting (D)

Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.

Chen Pong Wong (CP)

Department of Neuroradiology, Singapore General Hospital, Singapore, Singapore.

Guoyu Hu (G)

School of Computing, National University of Singapore, Singapore, Singapore.

Beng Chin Ooi (BC)

School of Computing, National University of Singapore, Singapore, Singapore.

Si Wei Kheok (SW)

Department of Neuroradiology, Singapore General Hospital, Singapore, Singapore.

Classifications MeSH